Nissay Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.16M | Buy |
14,901
+323
| +2% | +$63.4K | 0.01% | 449 |
|
|
2026
Q1 | $2.86M | Buy |
14,578
+138
| +1% | +$26.8K | 0.02% | 427 |
|
|
2025
Q4 | $2.51M | Buy |
14,440
+211
| +1% | +$38.4K | 0.01% | 462 |
|
|
2025
Q3 | $2.71M | Sell |
14,229
-38
| -0.3% | -$6.74K | 0.02% | 436 |
|
|
2025
Q2 | $2.56M | Buy |
14,267
+38
| +0.3% | +$6.6K | 0.02% | 456 |
|
|
2025
Q1 | $2.41M | Buy |
14,229
+192
| +1% | +$31.5K | 0.02% | 462 |
|
|
2024
Q4 | $2.14M | Buy |
14,037
+90
| +0.6% | +$14K | 0.01% | 501 |
|
|
2024
Q3 | $2.17M | Sell |
13,947
-772
| -5% | -$115K | 0.01% | 512 |
|
|
2024
Q2 | $2.01M | Buy |
14,719
+197
| +1% | +$27K | 0.01% | 496 |
|
|
2024
Q1 | $1.93M | Sell |
14,522
-47
| -0.3% | -$6.1K | 0.01% | 512 |
|
|
2023
Q4 | $2.01M | Buy |
14,569
+514
| +4% | +$67.6K | 0.02% | 464 |
|
|
2023
Q3 | $1.71M | Buy |
14,055
+416
| +3% | +$55.4K | 0.02% | 486 |
|
|
2023
Q2 | $1.92M | Sell |
13,639
-334
| -2% | -$46K | 0.02% | 451 |
|
|
2023
Q1 | $1.98M | Sell |
13,973
-688
| -5% | -$98.4K | 0.02% | 437 |
|
|
2022
Q4 | $2.29M | Sell |
14,661
-15,935
| -52% | -$2.29M | 0.02% | 400 |
|
|
2022
Q3 | $3.75M | Buy |
30,596
+4,907
| +19% | +$646K | 0.04% | 277 |
|
|
2022
Q2 | $3.42M | Sell |
25,689
-599
| -2% | -$81.6K | 0.03% | 286 |
|
|
2022
Q1 | $3.6M | Buy |
26,288
+378
| +1% | +$52.7K | 0.03% | 322 |
|
|
2021
Q4 | $4.48M | Buy |
25,910
+413
| +2% | +$62.8K | 0.03% | 296 |
|
|
2021
Q3 | $3.71M | Sell |
25,497
-5,987
| -19% | -$876K | 0.03% | 313 |
|
|
2021
Q2 | $4.16M | Buy |
31,484
+15,667
| +99% | +$2.05M | 0.04% | 278 |
|
|
2021
Q1 | $2.03M | Sell |
15,817
-294
| -2% | -$36.2K | 0.02% | 424 |
|
|
2020
Q4 | $1.92M | Buy |
16,111
+48
| +0.3% | +$5.85K | 0.03% | 407 |
|
|
2020
Q3 | $1.84M | Sell |
16,063
-4,914
| -23% | -$581K | 0.03% | 377 |
|
|
2020
Q2 | $2.39M | Sell |
20,977
-19,691
| -48% | -$2.09M | 0.05% | 332 |
|
|
2020
Q1 | $3.27M | Buy |
40,668
+939
| +2% | +$97.2K | 0.08% | 221 |
|
|
2019
Q4 | $4.24M | Sell |
39,729
-871
| -2% | -$90.8K | 0.09% | 233 |
|
|
2019
Q3 | $4.34M | Buy |
40,600
+4,383
| +12% | +$450K | 0.11% | 218 |
|
|
2019
Q2 | $3.69M | Sell |
36,217
-7,624
| -17% | -$733K | 0.09% | 244 |
|
|
2019
Q1 | $3.94M | Sell |
43,841
-6,968
| -14% | -$604K | 0.1% | 231 |
|
|
2018
Q4 | $4.23M | Buy |
50,809
+330
| +0.7% | +$30.9K | 0.13% | 197 |
|
|
2018
Q3 | $5.45M | Sell |
50,479
-17,202
| -25% | -$1.89M | 0.15% | 170 |
|
|
2018
Q2 | $7.44M | Buy |
67,681
+39,404
| +139% | +$4.1M | 0.22% | 115 |
|
|
2018
Q1 | $2.84M | Sell |
28,277
-186
| -0.7% | -$19.1K | 0.09% | 278 |
|
|
2017
Q4 | $2.8M | Buy |
+28,463
| New | +$2.7M | 0.09% | 293 |
|
Other funds holding DGX
EIG
Nissay Asset Management's DGX Position: Q2 2026 in Review
Nissay Asset Management increased its Quest Diagnostics (DGX) stake by 2.2% in Q2 2026, buying an estimated $63.4K and bringing the position to 14,901 shares worth $3.16M. The position accounts for 0.01% of the portfolio, ranked #449.
Nissay Asset Management first reported a position in DGX in Q4 2017 and has held it in 35 quarters since. The position peaked at $7.44M in Q2 2018. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Nissay Asset Management held 14,901 shares of Quest Diagnostics worth $3.16M as of Q2 2026.
- Nissay Asset Management bought 323 Quest Diagnostics shares in Q2 2026, an estimated $63.4K.
- Quest Diagnostics made up 0.01% of Nissay Asset Management's portfolio in Q2 2026, its #449 holding.
- Nissay Asset Management first reported a position in Quest Diagnostics in Q4 2017 and has held it in 35 quarters since.
- Nissay Asset Management's Quest Diagnostics position peaked at $7.44M in Q2 2018.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Nissay Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.